Pregabalin efficacy in painful diabetic peripheral neuropathy: A focused analysis of optimal dosing and the relationship of baseline glycemic control

Key Points

• The aim is to evaluate the efficacy of pregabalin for pain relief in diabetic peripheral neuropathy and its relationship with glycemic control.
• Analyzed the efficacy of pregabalin at 300 and 600 mg/day
• Assessed pain relief across different HbA1c levels
• Focused on dose optimization for maximal benefit
• Pregabalin at both doses provided significant pain relief
• Pain relief was effective regardless of baseline HbA1c levels
• Support for optimizing dosage to enhance therapeutic outcomes

Abstract